首页> 外国专利> Radioactive chitosan complex and its macroaggregates for use in internal radiation therapy and their preparation method

Radioactive chitosan complex and its macroaggregates for use in internal radiation therapy and their preparation method

机译:用于内部放射治疗的放射性壳聚糖复合物及其大分子聚集体及其制备方法

摘要

Radioactive chitosan complex and its macroaggregate and method for preparing thereof is capable of substituting conventional surgical operation and medicinal treatment method for hepatocellular carcinoma or metastasized liver cancer. Chitosan complex and its macroaggregate, a natural high molecular substance having a non-toxicity, bio-compatability and biodegradability are labelled with radionuclide (159Sm, 165Dy, 166Ho, 169Er) of emitting high energy beta-rays. The radioactive chitosan macroaggregate prepared as above is intrapercutaneously or intraartery injected to lesion of liver, so that it can be selectively more accumulated to a cancer cell than a normal tissue, and can treat by selectively killing the cancer cell by beta-rays emitted from the said radioactive nuclides. An ovarium cancer, a stomach cancer, a peritoneol cavity cancer, and a rheumatoid arthritis which are all known as incurable diseases can also be treated by selectively killing its lesion by means of this internal radiation therapy.
机译:放射性壳聚糖复合物及其大分子聚集体及其制备方法能够代替肝细胞癌或转移性肝癌的常规外科手术和药物治疗方法。壳聚糖复合物及其大分子聚集体是一种无毒,生物相容性和生物降解性的天然高分子物质,用放射性核素标记( 159 Sm, 165 Dy, 166 Ho, 169 Er)发出高能β射线。如上制备的放射性壳聚糖大分子聚集体经皮内或动脉内注射到肝脏病变处,因此与正常组织相比,它可以选择性地更多地积聚到癌细胞中,并且可以通过从癌细胞发出的β射线选择性杀死癌细胞来进行治疗。所说的放射性核素。卵巢癌,胃癌,腹膜腔癌和类风湿关节炎都被称为不可治愈的疾病,也可以通过这种内部放射疗法选择性杀死其病变来治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号